A role for hepatic-directed chemotherapy in colorectal liver metastases

被引：4

作者：

Ensminger, WD ^{[1
]}

机构：

[1] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA

[2] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA

[3] Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 22期

关键词：

D O I：

10.1200/JCO.2005.03.902

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4815 / 4817

页数：3

共 15 条

[1]

Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71

[2] REGIONAL CHEMOTHERAPY DEVICES - EFFECT OF EXPERIENCE AND ANATOMY ON COMPLICATIONS [J].

CAMPBELL, KA ;

BURNS, RC ;

SITZMANN, JV ;

LIPSETT, PA ;

GROCHOW, LB ;

NIEDERHUBER, JE .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (05) :822-826

[3] Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: A trial of the Gastrointestinal Group of the Federation Nationale des Centres de Lutte Contre le Cancer [J].

Ducreux, M ;

Ychou, M ;

Laplanche, A ;

Gamelin, E ;

Lasser, P ;

Husseini, F ;

Quenet, F ;

Viret, F ;

Jacob, JH ;

Boige, V ;

Elias, D ;

Delperro, JR ;

Luboinski, M .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :4881-4887

[4] Intrahepatic arterial infusion of chemotherapy: Pharmacologic principles [J].

Ensminger, WD .

SEMINARS IN ONCOLOGY, 2002, 29 (02) :119-125

[5] Improved hepatic toxicity profile of portal vein adjuvant hepatic infusional chemotherapy [J].

Faynsod, M ;

Wagman, LD ;

Longmate, J ;

Carroll, M ;

Leong, LA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :4876-4880

[6] Liver resection for colorectal metastases [J].

Fong, YM ;

Cohen, AM ;

Fortner, JG ;

Enker, WE ;

Turnbull, AD ;

Coit, DG ;

Marrero, AM ;

Prasad, M ;

Blumgart, LH ;

Brennan, MF .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :938-946

[7] A Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer [J].

Goldberg, RM ;

Sargent, DJ ;

Morton, RF ;

Fuchs, CS ;

Ramanathan, RK ;

Williamson, SK ;

Findlay, BP ;

Pitot, HC ;

Alberts, SR .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) :23-30

[8] Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - An intergroup study [J].

Kemeny, MM ;

Adak, S ;

Gray, B ;

Macdonald, JS ;

Smith, T ;

Lipsitz, S ;

Sigurdson, ER ;

O'Dwyer, PJ ;

Benson, AB .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) :1499-1505

[9] Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer [J].

Kemeny, N ;

Jarnagin, W ;

Paty, P ;

Gönen, M ;

Schwartz, L ;

Morse, M ;

Leonard, G ;

D'Angelica, M ;

DeMatteo, R ;

Blumgart, L ;

Fong, YM .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :4888-4896

[10]

KEMENY N, 1992, CANCER, V69, P327, DOI 10.1002/1097-0142(19920115)69:2<327::AID-CNCR2820690209>3.0.CO

← 1 2 →